Antimicrobial activity and beta-lactamase stability of BMY-28232, parent compound of an oral cephalosporin
- 1 November 1990
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 9 (11) , 841-846
- https://doi.org/10.1007/bf01967389
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin esterAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug estersAntimicrobial Agents and Chemotherapy, 1989
- Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.1987
- CefiximeThe Pediatric Infectious Disease Journal, 1987
- In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074)Antimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibioticAntimicrobial Agents and Chemotherapy, 1984
- Method of reliable determination of minimal lethal antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1980